Core Laboratories (CLB) Receivables (2022 - 2026)
Core Laboratories filings provide 5 years of Receivables readings, the most recent being $108.3 million for Q1 2026.
- On a quarterly basis, Receivables fell 8.08% to $108.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $108.3 million, a 8.08% decrease, with the full-year FY2025 number at $113.5 million, up 1.25% from a year prior.
- Receivables hit $108.3 million in Q1 2026 for Core Laboratories, down from $113.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $118.2 million in Q3 2024 to a low of $105.2 million in Q3 2023.
- Median Receivables over the past 5 years was $112.1 million (2024), compared with a mean of $112.3 million.
- Biggest five-year swings in Receivables: rose 12.35% in 2024 and later decreased 8.08% in 2026.
- Core Laboratories' Receivables stood at $108.1 million in 2022, then rose by 2.39% to $110.6 million in 2023, then grew by 1.34% to $112.1 million in 2024, then increased by 1.25% to $113.5 million in 2025, then dropped by 4.63% to $108.3 million in 2026.
- The last three reported values for Receivables were $108.3 million (Q1 2026), $113.5 million (Q4 2025), and $111.4 million (Q3 2025) per Business Quant data.